Medical Information

The medication of Orlistat for special populations needs to be adjusted according to individual differences such as pregnancy, lactation, liver and kidney function. During medication, attention should be paid to controlling fat intake and monitoring adverse reactions. The following items provide a detailed description of medication guidelines and precautions for special populations.

1. Medication for special populations

(1) Pregnancy period: There is insufficient data to prove the safety of orlistat for pregnant women, and animal studies have shown that it may affect fetal development. Its use should be avoided during pregnancy.

(2) Breastfeeding period: It is not clear whether the medication is secreted into breast milk. It is recommended that lactating women weigh the pros and cons before using it, and if necessary, suspend breastfeeding.

(3) Children: The safety and efficacy of children under 12 years old have not been established. Children aged 12-18 should be used under the guidance of a doctor and are not recommended as first-line treatment.

(4) Elderly: Patients over 65 years old do not need to adjust their dosage, but their nutritional status and liver function need to be closely monitored.

(5) Liver dysfunction: Use with caution in patients with mild to moderate liver dysfunction, and use with caution in patients with severe liver dysfunction, as it may increase the risk of drug accumulation.

(6) Renal insufficiency: No dosage adjustment is needed, but patients with end-stage renal disease have limited experience with it. It is recommended to strengthen monitoring.

2 Medication precautions

(1) Medication timing: It should be taken with meals or within 1 hour after meals, no more than 3 times a day. Dosage can be omitted when skipping meals or consuming low-fat food.

(2) Fat control: Daily dietary fat intake should be balanced, and the best effect is achieved when the single meal fat content exceeds 15g, but excessive intake can easily cause fat diarrhea.

(3) Nutritional supplementation: Long term medication requires the supplementation of fat soluble vitamins (A, D, E, K), and it is recommended to take them with a 2-hour interval before and after medication.

(4) Adverse reactions: Common oily spots, increased gastrointestinal exhaust, etc. If severe abdominal pain or jaundice occurs, medication should be stopped immediately and medical attention should be sought.

(5) Drug interaction: The dosage should be adjusted in combination with cyclosporine and warfarin, and the combination with anti diabetes drugs may enhance the hypoglycemic effect.

(6) Course management: It is recommended to use continuously for no more than 6 months, and those who are ineffective should re evaluate the treatment plan.